Physician profile
John Cappa
NPI 1336141233
$22,443.20
in general payments reported to CMS, 2019-2025
48 companies · $1,964 in 2025
The $1,964 reported for 2025 was more than what 90% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,502 · 2020: $583 · 2021: $1,684 · 2022: $4,551 · 2023: $7,081 · 2024: $5,079 · 2025: $1,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,055 · Travel and Lodging: $6,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,054.55 |
| Travel and Lodging | $6,068.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $5,783.27 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $4,659.66 | 2019-2025 | Grafix, Stravix Pl, Oasis |
| Organogenesis INC. | $1,759.18 | 2019-2025 | Apligraf, Puraply Wound Matrix, Affinity |
| Stryker Corporation | $1,727.61 | 2022-2025 | Prostep, Dart-Fire, Graftjacket |
| Arthrex, INC. | $977.70 | 2024 | |
| Paratek Pharmaceuticals, INC. | $934.97 | 2020-2025 | Nuzyra |
| Abbvie INC. | $847.88 | 2021-2025 | Dalvance |
| Gotham Surgical Solutions & Devices, INC. | $515.94 | 2023-2024 | |
| Kci USA, INC. | $506.46 | 2019-2023 | V.A.C. Dermatac, V.A.C. Veraflo, V.A.C.Ulta |
| Next Science LLC | $457.07 | 2023-2024 | Surgx, Xperience, Blastx |
| Nevro Corp. | $455.08 | 2021-2022 | |
| Bone Support INC. | $281.97 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Bioventus LLC | $248.80 | 2022-2023 | Theragenesis Bilayer Wound Matrix |
| Treace Medical Concepts, INC. | $247.65 | 2022-2025 | |
| Integra Lifesciences Corporation | $229.71 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $220.34 | 2024 | |
| Cardiovascular Systems INC. | $200.00 | 2019 | |
| Boston Scientific Corporation | $185.93 | 2023-2025 | Ranger, General - Pain Management |
| Melinta Therapeutics, LLC | $185.60 | 2019-2023 | Orbactiv, Kimyrsa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $162.54 | 2020-2022 | |
| Solventum Corporation | $158.25 | 2024 | Activ.A.C., V.A.C.Ulta, V.A.C. Dermatac |
| Polarityte, INC. | $153.24 | 2019 | |
| Paragon 28, INC. | $143.30 | 2024-2025 | Precision Mis Bunion |
| Spr Therapeutics, INC | $141.38 | 2025 | Sprint Pns System |
| Lifenet Health | $139.60 | 2025 | Theragenesis Wound Matrix |
| Polynovo North America LLC | $137.10 | 2023-2025 | Novosorb Btm |
| Ani Pharmaceuticals, INC. | $125.00 | 2024 | Purified Cortrophin Gel |
| Access Pro Medical, LLC | $117.46 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $103.93 | 2023 | Seglentis |
| Djo, LLC | $77.05 | 2024-2025 | Cmf |
| Alfasigma USA, INC. | $58.50 | 2021-2022 | |
| Grt US Holding, INC. | $58.42 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $56.43 | 2025 | Caldolor |
| Ekos Corporation | $56.32 | 2019 | |
| Reprise Biomedical, INC. | $42.04 | 2022-2024 | Miro3d |
| Acell, INC. | $38.56 | 2020 | |
| Zimmer Biomet Holdings, INC. | $29.41 | 2022 | |
| Horizon Therapeutics Plc | $26.71 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $23.48 | 2022 | |
| Medtronic, INC. | $23.39 | 2024 | Intellis Adaptivestim |
| Medela LLC | $22.28 | 2021 | |
| Tactile Systems Technology INC | $22.11 | 2019 | |
| Biocomposites INC | $21.98 | 2025 | Stimulan |
| Sebela Pharmaceuticals INC. | $20.69 | 2023 | Pramosone, Naftin |
| Mimedx Group, INC. | $17.61 | 2024 | |
| Hydrofera LLC | $14.71 | 2022 | |
| Zyla Life Sciences, INC. | $13.80 | 2019 | |
| Advanced Oxygen Therapy INC. | $13.09 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cappa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.